Market Closed -
TEL AVIV STOCK EXCHANGE
08:49:40 2024-06-02 EDT
|
5-day change
|
1st Jan Change
|
1,916
ILa
|
-0.93%
|
|
-0.05%
|
-13.96%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
960.1
|
924.6
|
920.4
|
615
|
1,280
|
1,101
|
-
|
-
|
Enterprise Value (EV)
1 |
960.1
|
924.6
|
920.4
|
615
|
1,280
|
1,101
|
1,101
|
1,101
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.2
x
|
2.13
x
|
2.7
x
|
1.31
x
|
2.51
x
|
1.86
x
|
1.66
x
|
1.42
x
|
EV / Revenue
|
2.2
x
|
2.13
x
|
2.7
x
|
1.31
x
|
2.51
x
|
1.86
x
|
1.66
x
|
1.42
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
14,821,198
x
|
-
|
-
|
-
|
EV / FCF
|
11.5
x
|
22.5
x
|
-22.1
x
|
-
|
-233
x
|
15.7
x
|
11.6
x
|
7.99
x
|
FCF Yield
|
8.72%
|
4.44%
|
-4.52%
|
-
|
-0.43%
|
6.38%
|
8.65%
|
12.5%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
40,512
|
44,731
|
44,786
|
44,826
|
57,476
|
57,480
|
-
|
-
|
Reference price
2 |
23.70
|
20.67
|
20.55
|
13.72
|
22.27
|
19.16
|
19.16
|
19.16
|
Announcement Date
|
20-02-12
|
21-02-10
|
22-03-15
|
23-03-15
|
24-03-06
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
436.2
|
433.1
|
340.3
|
469.1
|
510.9
|
591.8
|
665.2
|
773.3
|
EBITDA
|
-
|
-
|
-
|
-
|
86.36
|
-
|
-
|
-
|
EBIT
1 |
78.14
|
62.53
|
-2.286
|
16.44
|
36.08
|
72.95
|
78.33
|
112.2
|
Operating Margin
|
17.91%
|
14.44%
|
-0.67%
|
3.5%
|
7.06%
|
12.33%
|
11.78%
|
14.51%
|
Earnings before Tax (EBT)
1 |
78.81
|
60.35
|
-6.19
|
-8.192
|
30.22
|
61.52
|
75.03
|
108.6
|
Net income
1 |
76.31
|
55.72
|
-7.323
|
-8.417
|
29.7
|
53.64
|
63.7
|
92.23
|
Net margin
|
17.49%
|
12.86%
|
-2.15%
|
-1.79%
|
5.81%
|
9.06%
|
9.58%
|
11.93%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
83.7
|
41.06
|
-41.62
|
-
|
-5.499
|
70.22
|
95.3
|
137.8
|
FCF margin
|
19.19%
|
9.48%
|
-12.23%
|
-
|
-1.08%
|
11.86%
|
14.33%
|
17.82%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
109.69%
|
73.69%
|
-
|
-
|
-
|
130.89%
|
149.62%
|
149.41%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20-02-12
|
21-02-10
|
22-03-15
|
23-03-15
|
24-03-06
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
103.3
|
95.31
|
76.9
|
111.8
|
164.8
|
113.6
|
140.1
|
146.1
|
130.6
|
140.3
|
145.9
|
149.9
|
156.5
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-10.84
|
0.8346
|
-7.478
|
8.893
|
14.57
|
1.069
|
9.846
|
16.82
|
9.951
|
15.01
|
15.22
|
16.26
|
26.78
|
Operating Margin
|
-10.49%
|
0.88%
|
-9.72%
|
7.95%
|
8.84%
|
0.94%
|
7.03%
|
11.51%
|
7.62%
|
10.7%
|
10.43%
|
10.85%
|
17.11%
|
Earnings before Tax (EBT)
1 |
-15.32
|
-6.063
|
-12.75
|
1.715
|
10.68
|
-6.641
|
7.129
|
12.69
|
18.01
|
9.065
|
13.38
|
14.43
|
24.94
|
Net income
1 |
-16.45
|
-6.202
|
-12.78
|
1.68
|
10.68
|
-6.689
|
6.781
|
12.41
|
18.13
|
8.79
|
11.82
|
12.87
|
21.14
|
Net margin
|
-15.92%
|
-6.51%
|
-16.62%
|
1.5%
|
6.48%
|
-5.89%
|
4.84%
|
8.5%
|
13.88%
|
6.27%
|
8.1%
|
8.59%
|
13.51%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22-03-15
|
22-05-17
|
22-08-17
|
22-11-22
|
23-03-15
|
23-05-24
|
23-08-16
|
23-11-13
|
24-03-06
|
24-05-08
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
83.7
|
41.1
|
-41.6
|
-
|
-5.5
|
70.2
|
95.3
|
138
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
7.89
|
17.9
|
12.2
|
13.7
|
21
|
1.81
|
1.45
|
1.15
|
Capex / Sales
|
1.81%
|
4.12%
|
3.59%
|
2.93%
|
4.1%
|
0.31%
|
0.22%
|
0.15%
|
Announcement Date
|
20-02-12
|
21-02-10
|
22-03-15
|
23-03-15
|
24-03-06
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -13.96% | 299M | | -2.29% | 89.87B | | -3.95% | 37.57B | | +63.05% | 26.47B | | -22.14% | 14.25B | | -7.96% | 12.99B | | -9.33% | 11.93B | | -46.33% | 10.84B | | +5.77% | 9.11B | | -17.66% | 7.32B |
Biopharmaceuticals
|